PubMed

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS.

Diabetes Care. 2003 Nov;26(11):2983-9.PMID: 14578227 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.

Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.

Clin Ther. 2004 Sep;26(9):1400-10.PMID: 15531002 [PubMed - indexed for MEDLINE]Related articles

Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

Inzucchi SE, Masoudi FA, Wang Y, Kosiborod M, Foody JM, Setaro JF, Havranek EP, Krumholz HM.

Diabetes Care. 2005 Jul;28(7):1680-9.PMID: 15983320 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.

JAMA. 2007 Dec 12;298(22):2634-43.PMID: 18073359 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.PMID: 18693776 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.

Granberry MC, Hawkins JB, Franks AM.

Am J Health Syst Pharm. 2007 May 1;64(9):931-6. Review.PMID: 17468147 [PubMed - indexed for MEDLINE]Related articles

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.

Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):504-12.PMID: 17245800 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone initiation and subsequent hospitalization for congestive heart failure.

Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM.

Diabet Med. 2005 Aug;22(8):986-93.PMID: 16026362 [PubMed - indexed for MEDLINE]Related articles

Considerations for management of fluid dynamic issues associated with thiazolidinediones.

Hollenberg NK.

Am J Med. 2003 Dec 8;115 Suppl 8A:111S-115S. Review.PMID: 14678876 [PubMed - indexed for MEDLINE]Related articles

Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.

Shaya FT, Shin JY, Mullins D, Fatodu HO, Gu A, Saunders E.

J Natl Med Assoc. 2005 Apr;97(4):493-7.PMID: 15868769 [PubMed - indexed for MEDLINE]Related articlesFree article

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

Aquilante CL, Zhang W, McCollum M.

Curr Med Res Opin. 2007 Mar;23(3):489-94.PMID: 17355730 [PubMed - indexed for MEDLINE]Related articles

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.

Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A.

J Am Coll Cardiol. 2007 Jul 3;50(1):32-6. Epub 2007 Jun 18.PMID: 17601542 [PubMed - indexed for MEDLINE]Related articles

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study: response to Delea et al.

Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM, Ferrara A, Selby JV.

Diabetes Care. 2004 Mar;27(3):850-1; author reply 852-3. No abstract available. PMID: 14988326 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.

Hartung DM, Touchette DR, Bultemeier NC, Haxby DG.

Pharmacotherapy. 2005 Oct;25(10):1329-36.PMID: 16185176 [PubMed - indexed for MEDLINE]Related articles

Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs).

Dorais M, LeLorier J.

Can J Clin Pharmacol. 2008 Winter;15(1):e15-21. Epub 2008 Jan 9.PMID: 18184984 [PubMed - indexed for MEDLINE]Related articlesFree article

Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.

Maru S, Koch GG, Stender M, Clark D, Gibowski L, Petri H, White AD, Simpson RJ Jr.

Diabetes Care. 2005 Jan;28(1):20-6.PMID: 15616228 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.

Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM.

Circulation. 2005 Feb 8;111(5):583-90.PMID: 15699279 [PubMed - indexed for MEDLINE]Related articlesFree article

Managing type 2 diabetes: going beyond glycemic control.

Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.

J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.PMID: 18597582 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.

Koro CE, Sowell MO, Stender M, Qizilbash N.

Clin Ther. 2008 Mar;30(3):535-42.PMID: 18405791 [PubMed - indexed for MEDLINE]Related articles